Skip to main content

Pharmaco Vigilance

Search form

Search

Home
Perspectives
Case Reports
Focus on
Columns
News
Links

About us
Contacts

Primary tabs

View(active tab)
What links here

SMS-based active surveillance of adverse events following immunization in children: the VigiVax study

© 2011-2024 | Zadig srl Società Benefit | P.IVA: 10983300152

80.211.154.110